Rationale for the Use of Nonabsorbable Antibiotics in the Treatment of Urinary Infections: Follow-Up Report
Gram-negative bacteria, particularly those that comprise the loosely termed coliform group, are responsible for 70–80% of urinary infections(1–4). This is true for patients in a domiciliary as well as a hospital practice(5,6), through the frequency of infecting organisms varies considerably between these two groups.
KeywordsRheumatic Fever Urinary Infection Urethral Catheter Phenyl Ethyl Alcohol Recurrent Urinary Infection
Unable to display preview. Download preview PDF.
- 1.Campbell, M. F., Urology, W. B. Saunders Company, Philadelphia, Vol. 1, pp. 381–405, 1963.Google Scholar
- 4.Schwarz, H., Schirmer, H., Ehlers, B., and Post, B. Urinary tract infections: Correlation between organisms obtained simultaneously from the urine and feces of patients with bacteriuria and pyuria. J. Urol. 101: 756–767, 1969.Google Scholar
- 5.O’Grady, F., and Brumfitt, W. Urinary Tract Infection, Oxford University Press, London, pp. 68–79, 1968.Google Scholar
- 8.Poth, E. J., and Ross, C. A. The clinical use of phthalylsulfathiazole. J. Lab. Clin. Med. 29: 785–808, 1944.Google Scholar
- 10.Everett, H. S., Scott, R. B., and Steptoe, P. P. The treatment of urinary infections with sulfasuxidine (succinylsulfathiazole). Am. J. Obstet. Gynec. 49: 114–127, 1945.Google Scholar
- 11.Ewing, W. H. Isolation and Identification of E. coli Serotypes Associated with Diarrhea! Diseases, CDC Laboratory Manual, U.S. Dept. H.alth, Education and Welfare, Public Health Service, Communicable Disease Center, Laboratory Branch, Atlanta, Georgia, p. 10, 1963.Google Scholar
- 13.Poth, E. J. Sulfasuxidine and sulfathalidine. Texas Rep. Biol. Med. 4: 68–102, 1946.Google Scholar
- 14.Goodman, L. S., and Gillman, A. The Pharmacological Basis of Therapeutics. Macmillan, New York, pp. 1158–1160, 1965.Google Scholar